openPR Logo
Press release

Global Bug Resistant Medicines Market to Record Rise in Incremental Opportunity During the Forecast Period-2018 - 2028

Global Bug Resistant Medicines Market to Record Rise

Bug-resistant medicines are the drugs which are used to stop the infection that is caused by the germs or the bugs i.e. antimicrobials in many cases. There are several drugs which are approved by food and drug administration recently like Ceftolozane/tazobactam, Sivextro, Zerbaxa among others that fight against these kinds of bugs (bacterial strains). When bugs resist several varieties of the antibiotics, then they are known as superbugs. According to the Centers for Disease Control and Prevention (CDC), Antibiotic-Resistant Superbug is becoming an emerging threat to all the people across the world. Thus, Bug-resistant medicines are introduced in this way to the Bug-resistant medicines market. Increase in such kind of infection increases the demand of the bug resistant disease. Around 70% of the bugs that cause such kind of infections are resistant to at least one of the antibiotics generally needed to treat them. 490 000 people developed multi-drug resistant Tuberculosis across the world, and drug resistance is outset to impede the fight against deadly diseases such as HIV and malaria in 2016.

As per the Centers for Disease Control and Prevention (CDC), drug-resistant infections reported for around 2 million infections with antimicrobial-resistant bacteria that leads to approximately 23,000 deaths in the United States of America annually. Increasing the prevalence of chronic diseases across the globe drives the Bug-resistant medicines market. Manufacturers are focusing on the research and development of such type of drugs which helps the patient to recover at the earliest. These bugs can spread mostly from patients in hospitals. Some of the applications that bug-resistant medicines offers include oncology, immunology, neurology, cardiology, respiratory, infectious diseases and others. Other factors such as the increased burden of genetic diseases such as diabetes among others are expected to boost the growth of the bug-resistant medicines market. The mutation occurs in the microbial strains causes its behavior negative to these medicines.

Generally, the global Bug-Resistant Medicines market can be segmented on the basis of Drugs, distribution channel & regions.

On the basis of Drugs, the Bug-Resistant Medicines market is segmented as:

Antiviral
Antifungal
Antibacterial
Others

On the basis of distribution channel, the Bug-Resistant Medicines market is segmented as:

Hospitals
Clinics
Ambulatory Care Center
Others

The global Bug-Resistant Medicines market is expected to grow with a moderately increasing CAGR due to the increasing adoption and demand for Bug-Resistant Medicines. Based on the Drugs, it is observed that Antibacterial is done at most of the cases. It is analyzed that, On the basis of end users, hospital segment will hold the maximum market revenue share in the global Bug-Resistant Medicines market over the forecast period. One of the most common uses of Bug-Resistant Medicines is to control the effect of bugs i.e. infection

On the basis of geography, the global Bug-Resistant Medicines market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China, and the Middle East & Africa. The North America Bug-Resistant Medicines market is expected to contribute maximum market share in the global Bug-Resistant Medicines market which is followed by Europe Bug-Resistant Medicines market. The Asia Pacific Bug-Resistant Medicines market is expected to grow with a maximum CAGR over the forecast period due to less awareness among the people while the Latin America Bug-Resistant Medicines market and the Middle East and Africa concerned market is expected to show steady growth rate over the forecast period. It is estimated that the Middle East and Africa concerned market is to be dominated by South Africa.

Some of the key players present in the global concerned market are F. Hoffmann-La Roche Ltd, Sanofi, Novartis International AG, Pfizer Inc. AbbVie Inc. Gilead, Amgen Inc., GlaxoSmithKline plc. Johnson & Johnson Services, Inc. among others.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bug Resistant Medicines Market to Record Rise in Incremental Opportunity During the Forecast Period-2018 - 2028 here

News-ID: 1504969 • Views:

More Releases from Persistence Market Research

North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032, PMR Reports
North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032 …
The North America household washer and dryer market is poised for steady growth, supported by rising demand for smart home appliances, changing lifestyle patterns, and technological enhancements in laundry equipment. The market is projected to reach US$ 17.3 billion in 2025, and with a CAGR of 3.5% from 2025 to 2032, it is expected to climb to US$ 22.2 billion by 2032. ➤ Download Your Free Sample & Explore Key Insights:
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Interiors Surges
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Inter …
The global indoor plants market is poised for sustained expansion over the next several years. According to Persistence Market Research, the market is projected to grow from US$ 22.6 billion in 2025 to US$ 32.7 billion by 2032, reflecting a CAGR of 5.4% during the forecast period. This upward trajectory underscores the increasing consumer shift toward wellness-driven living, biophilic interiors, and nature-connected home environments. ➤ Download Your Free Sample & Explore
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 2032
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 203 …
The global UV disinfection equipment market is poised for remarkable expansion over the next decade. Industry estimates indicate that the market will be valued at US$ 17.0 billion in 2025 and is projected to surge to US$ 48.9 billion by 2032, registering a powerful CAGR of 16.3% between 2025 and 2032. This accelerated growth reflects heightened global focus on safety, hygiene, water quality, and chemical-free disinfection methods across both residential
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports PMR
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports …
The global surfing apparel and accessories market is set for steady expansion over the next several years. According to industry estimates, the market is anticipated to rise from US$ 9.5 billion in 2024 to US$ 14.1 billion by 2031, reflecting a healthy CAGR of 5.5% during the forecast period. This upward trajectory highlights the increasing global appeal of surfing as both a sport and a lifestyle. ➤ Download Your Free Sample

All 5 Releases


More Releases for Medicines

Global Veterinary Medicines And Vaccines Market Size by Application, Type, and G …
According to Market Research Intellect, the global Veterinary Medicines And Vaccines market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The veterinary medicines and vaccines market is expanding steadily due to rising pet ownership, livestock farming,
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the
Regenerative Medicines: Bone and Joint Applications
Summary: The global market for regenerative medicine for bone and joint applications was valued at REDACTED in 2021. By technology, this market is segmented into biomaterials, stem cell therapy and tissue engineering. The tissue engineering segment recorded REDACTED revenue in 2021 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED during the forecast period. The rapid growth rate of the tissue engineering segment is attributed to
Herbal Medicinal Products Market Report 2018: Segmentation by Type (Ayurvedic Me …
Global Herbal Medicinal Products market research report provides company profile for Arkopharma SA, Nutraceutical Corporation, Blackmore Limited, Potters Herbal Medicine, NBTY Inc, Bio-Botanica Inc, Himalaya Drug Company, Twinlab Corporation, Arizona Natural Products and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
Market Access for Oncology Medicines to Witness Incredibly Challenging Owing to …
Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more stringent scientific and value assessments and economic pressures on national budgets and health systems. Although, 5EU markets have implemented patient access schemed to ensure early access to innovative oncology medicines with high unmet need, the increasing requirements for improved clinical benefits and better cost-effectiveness of medicines has resulted in more stringent
Animal Pharm - Medicines for Aquaculture 2016
ReportsWorldwide has announced the addition of a new report title Animal Pharm - Medicines for Aquaculture 2016 to its growing collection of premium market research reports. The fast-growing aquaculture health industry is of increasing interest to the mainstream animal health sector. This is demonstrated by the entry and expansion of the big global players into this market i.e. MSD, Elanco and Zoetis among others. It is estimated to be worth around